Sildenafil: study of a novel oral treatm
โ
Price, D.E.; Gingell, J.C.; Gepi-Attee, S.; Wareham, K.; Yates, P.; Boolell, M.
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 94 KB
๐ 2 views
The efficacy and safety of oral sildenafil, a potent inhibitor of phosphodiesterase type 5, were evaluated in men with diabetes mellitus and erectile dysfunction (ED). Twenty-one men (aged 42-65 years) were enrolled in a double-blind, placebo-controlled, three-way crossover study conducted in two pa